南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

一种通用保守的OMV-YidR结合纳米疫苗,可为抵御高毒力及耐碳青霉烯肺炎克雷伯菌提供广泛保护。

A universally conserved OMV-YidR conjugate nanovaccine confers broad protection against hypervirulent and carbapenem-resistant Klebsiella pneumoniae

Shuangjun He, Yang Zhang, Ahui Song, Chenyu Fan, Feng Zhao, Wei Zhou, Cuiying Xie, Chu Guo, Shengliang Chen, Yi Chen

Journal:Emerging Microbes & Infections

IF:7

DOI:10.1080/22221751.2026.2731500

PMID:

Published:2026-09-16

research field:肿瘤学分子生物学遗传学与基因组学

Abstract

The escalating crisis of multi-drug resistant (MDR) Klebsiella pneumoniae (KP) renders standard antibiotic treatments increasingly ineffective, necessitating a shift towards alternative approaches like vaccination. However, the development of a broadly protective vaccine remains hindered by the pathogen's extensive serotype diversity. To overcome this limitation, we targeted YidR – a highly conserved protein with potential as a universal antigen – and engineered a semi-synthetic conjugate vaccine by covalently linking it to KP-derived outer membrane vesicles (OMVs). The OMV-YidR conjugate successfully overcame the poor intrinsic immunogenicity of soluble YidR, eliciting robust antigen-specific IgG titres >20,000-fold higher than the unconjugated protein. Furthermore, the conjugate vaccine drove a shift from a weak Th2 bias to a potent, protective Th1/Th17 cellular profile. Crucially, this enhanced immunogenicity translated into broad-spectrum efficacy: while unconjugated OMVs protected only against the homologous strain, the OMV-YidR conjugate conferred complete (100%) survival against lethal challenges with diverse clinical isolates, including hypervirulent and carbapenem-resistant lineages. Mechanistic and comparative analyses revealed that covalent linkage – rather than simple physical co-administration – was essential for this superior efficacy, which was correlated with the preferential trafficking and uptake of the antigen by B cells in the draining lymph nodes. These findings establish the OMV-YidR conjugate as a highly potent, universal vaccine candidate capable of bypassing serotype limitations to prevent untreatable MDR K. pneumoniae infections.

本文使用的Yeasen产品

购物车
客服
转染试用